MassIVE MSV000082520

Partial Public PXD010262

MudPIT analyses of the chromatin associated proteins isolated from the nucleus of Plasmodium falciparum at three time-points of the intraerythrocytic development cycle

Description

Parasite cultures- Plasmodium falciparum strain 3D7 was cultured in human O+ erythrocytes at 5% hematocrit. Cultures were synchronized at ring stage with 5% (w/v) D-sorbitol treatments. Parasite cultures (8% parasitemia in 5% hematocrit) were harvested 48 hours after the first sorbitol treatment (ring stage) and 18 hours (trophozoite stage), and 36 hours thereafter (schizont stage). Chromatin enrichment for proteomics (ChEP)- Chromatin-associated proteins (CAPs) were isolated at three different stages of the parasite erythrocytic cycle: early ring (0 hours post infection), early trophozoite (18-hpi), and late schizont stages (36-hpi). Synchronized parasites were cross-linked with 1% formaldehyde for 15 min at 37oC. Cross-linking was quenched by adding 0.125 M glycine for 5 min at room temperature. The parasites were then washed with phosphate-buffered saline (PBS), incubated in nuclear extraction buffer (10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM AEBSF, protease inhibitor cocktail (Roche) and 0.25% Igepal) for 30 min and needle sheared using a 25-gauge needle. Extracted nuclei were spun at 1,300 rcf for 20 min at 4oC. The nuclear pellet was washed with highly denaturing extraction buffers containing 4% SDS and 8M urea to wash away non-cross-linked proteins. Chromatin was solubilized and genomic DNA was sheared by sonication (Covaris; 5% duty cycle, 140 intensity peak incident power, 200 cycles per burst). Cytoplasmic fractions- As a negative control, protein from the cytoplasmic fractions isolated from parasites at the same time-points were also extracted. Synchronized parasite cultures were collected and subsequently lysed by incubating in 0.15% saponin for 10 min on ice. Parasites were centrifuged at 1,500 rcf for 10 min at 4oC and washed three times with PBS. For each wash, parasites were resuspended in cold PBS and centrifuged for 10 min at 1,500 rcf at 4oC. After the last wash, parasites were resuspended in PBS, transferred to a microcentrifuge tube, and centrifuged for 5 min at 2100 rcf at 4oC. Subsequently, the parasite pellet was resuspended in 1.5X volume of cytoplasmic lysis buffer (0.65% Igepal CA-360 (Sigma-Aldrich), 10 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2 mM 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF), and EDTA-free protease inhibitor cocktail (Roche) and lysed by passing through a 26G 1/2-inch needle fifteen times. Parasite nuclei were centrifuged at 14,500 rcf for 15 min at 4oC and the supernatant containing the cytoplasmic extract was collected. Multidimensional Protein Identification Technology- Two biological replicates with two technical replicates each were prepared for ChEP and cytoplasmic control samples at the ring, trophozoite, and schizont stages. Proteins were precipitated with 20% trichloroacetic acid (TCA) and the resulting pellet was washed once with 10% TCA and twice with cold acetone. About 50 ug of the TCA-precipitated protein pellet was solubilized using Tris-HCl pH 8.5 and 8 M urea, followed by addition of TCEP (Tris(2-carboxyethyl)phosphine hydrochloride; Pierce) and CAM (chloroacetamide; Sigma) were added to a final concentration of 5 mM and 10 mM, respectively. Proteins were digested using Endoproteinase Lys-C at 1:100 w/w (Roche) at 37oC overnight. The samples were brought to a final concentration of 2 M urea and 2 mM CaCl2 and a second digestion was performed overnight at 37oC using trypsin (Promega) at 1:100 w/w. The reactions were stopped using formic acid (5% final). The samples were loaded on a split-triple-phase fused-silica micro-capillary column and placed in-line with a linear ion trap mass spectrometer (LTQ, Thermo Scientific), coupled with a Quaternary Agilent 1100 Series HPLC system. A fully automated 10-step chromatography run was carried out. Each full MS scan (400-1600 m/z) was followed by five data-dependent MS/MS scans. The number of the micro scans was set to 1 both for MS and MS/MS. The settings were as follows: repeat count 2; repeat duration 30 s; exclusion list size 500 and exclusion duration 120 s, while the minimum signal threshold was set to 100. The MS/MS data set was searched using ProLuCID (v. 1.3.3) against a database consisting of 5,530 P. falciparum non-redundant proteins (PlasmoDB-34), 36,628 Homo sapiens NR proteins (NCBI -released June 10, 2016), 193 usual contaminants, and, to estimate false discovery rates (FDRs), 42,351 randomized amino acid sequences derived from each NR protein entry. To account for alkylation by CAM, 57 Da were added statically to the cysteine residues. To account for the oxidation of methionine to methionine sulfoxide, 16 Da were added as a differential modification to the methionine residue. Peptide/spectrum matches were sorted and selected to an FDR less than 5% at the peptide and protein levels, using DTASelect in combination with swallow, an in-house software. [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Chromatin Enrichment for Proteomics (ChEP) ; Chromatin-Associated Proteins (CAPs) ; Chromatin Structure ; Genome Architecture

Contact

Principal Investigators:
(in alphabetical order)
Laurence Florens, The Stowers Institute for Medical Research, USA
Submitting User: laflorens

Publications

Batugedara G, Lu XM, Saraf A, Sardiu ME, Cort A, Abel S, Prudhomme J, Washburn MP, Florens L, Bunnik EM, Le Roch KG.
The chromatin bound proteome of the human malaria parasite.
Microb Genom. Epub 2020 Feb 4.

Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.